drugset / Trial / NCT01336803

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

NCT01336803

Phase 2 Completed 32 enrolled Heike E Daldrup-Link
NaSingle-groupOpen-labelDiagnostic

Summary

This pilot trial studies the differentiation of bone sarcomas and osteomyelitis with ferumoxytol-enhanced magnetic resonance imaging (MRI). Imaging procedures that allow doctors to more accurately differentiate between malignant bone sarcomas and osteomyelitis may help in diagnosing patients correctly and may result in more timely treatment.

Timeline

Start
2011-08
Primary completion
2014-07
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferumoxytol Diagnostic / imaging agent 5 mg/kg Intravenous